Olumiant (Baricitinib)

Baricitinib is a once daily, oral selective Janus kinase (JAK) inhibitor for the treatment of adult patients with moderately to severely active rheumatoid arthritis who have had an inadequate response to 1 or more tumor necrosis factor (TNF) antagonist therapies. JAK...